Sglt2 Inhibitors Are Associated With Reduced Cardiovascular Disease For Patients With Type 2 Diabetes | Latest News RSS feed

Sglt2 Inhibitors Are Associated With Reduced Cardiovascular Disease For Patients With Type 2 Diabetes - Latest News


SGLT2 Inhibitors are Associated with Reduced Cardiovascular Disease for Patients with Type 2 Diabetes

SAN DIEGO, June 13, 2017 /PRNewswire-USNewswire/ -- A new class of medication, known as sodium-glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalization for ... read more

Oral SGLT2 Inhibitors and You

Or if you have heart disease, congestive heart failure, or kidney disease, SGLT2 inhibitors may reduce your symptoms ... they lowered cardiovascular disease, and for many patients with type 2 diabetes ... read more

Pumps, Pipes, and Filters: SGLT2 Inhibitors for Most Type 2 Diabetes?

"These data suggest that SGLT2 inhibitors should be considered in patients with type 2 diabetes regardless of presence of atherosclerotic cardiovascular disease or history of heart failure, given that ... read more

Looking for another news?


SGLT-2 Inhibitors for Type 2 Diabetes: Renal and Urinary Issues

Type 2 diabetes ... 2,5 SGLT-2 inhibitor therapy is associated with reductions in systolic and diastolic blood pressure (~2 to 5 mm Hg) with no compensatory increases in heart rate. 3,6 These effects ... read more


SGLT-2 Inhibitors: The Best Bet Among New T2D Drugs?

Again, there was no difference when SGLT-2 inhibitors and GLP-1 agonists were compared with each other. SGLT-2 inhibitors were associated with reduced heart failure events ... all-cause mortality in ... read more

DECLARE: Dapagliflozin Offers Benefits for Diabetes Patients With Heart Failure

New findings show reduced hospitalizations for a wide group of patients ... in type 2 diabetes mellitus based on ejection fraction [published online March 18, 2019]. Circulation. Verma S, McMurray JJV ... read more

What Are the Pros and Cons of SGLT2 Inhibitors for Type 2 Diabetes?

You have several options for treating type 2 diabetes ... The NEJM suggested that the SGLT2 inhibitor dapagliflozin helps people with diabetes from being hospitalized for heart failure, regardless of ... read more

SGLT2 inhibitors offer hope for managing heart failure in diabetes

Patients with type 2 diabetes are most likely to develop HF with preserved ejection fraction (HFPEF) rather than valve disease ... associated with SGLT2 inhibitors may extend to a broad population of ... read more

SGLT2 Inhibitors are Associated with Reduced Cardiovascular Disease for Patients with Type 2 Diabetes

SAN DIEGO, June 13, 2017/PRNewswire-USNewswire/ -- A new class of medication, known as sodium-glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalization for ... read more

SGLT2 Inhibitors May Reduce CV, Renal Risks in Type 2 Diabetes

SGLT2i reduced the risks for progression of renal disease by 45% and heart failure hospitalization by 31% in patients ... et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular ... read more

Cardiovascular Benefit With SGLT2 Inhibition

Buse, MD, PhD, discusses the potential reasons for the cardiovascular risk reduction benefits associated with SGLT2 inhibition in patients with type 2 diabetes ... about the SGLT2 inhibitors is, how ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us